Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02481011 |
Date of registration:
|
22/06/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs
RICH |
Scientific title:
|
Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs: a Nationwide Study |
Date of first enrolment:
|
May 2015 |
Target sample size:
|
22111 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02481011 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Norway
| | | | | | | |
Contacts
|
Name:
|
Sasha Gulati, md phd |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Norwegian University of Science and Technology |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- hospitalization due to intracranial hemorrhage (ICH)
- residential address in Norway
Exclusion Criteria:
- Traumatic (high-energy) intracranial injury
- Parenteral antithrombotic treatment
- ICH related to tumor or vascular malformation
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Intracranial Hemorrhages
|
Stroke
|
Intervention(s)
|
Drug: antithrombotic drugs
|
Primary Outcome(s)
|
incidence rate of intracranial hemorrhage (ICH) requiring hospitalization
[Time Frame: 6 years]
|
Secondary Outcome(s)
|
overall survival following ICH
[Time Frame: 6 years]
|
proportion of ICH patients undergoing neurosurgical procedures
[Time Frame: 6 years]
|
Secondary ID(s)
|
2014/7958
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|